- Home
- PSFE vs SGHT Comparison
PSFE vs SGHT Comparison
Compare PSFE & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSFE | SGHT |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.4M | 395.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PSFE | SGHT |
|---|---|---|
| Price | $7.80 | $6.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $10.60 | $8.23 |
| AVG Volume (30 Days) | ★ 576.1K | 329.1K |
| Earning Date | 03-03-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,683,103,000.00 | $76,052,000.00 |
| Revenue This Year | $1.95 | N/A |
| Revenue Next Year | $6.21 | $12.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.43 | $2.03 |
| 52 Week High | $24.11 | $9.24 |
Technical Indicators
Market Signals| Indicator | PSFE | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 36.37 |
| Support Level | $7.99 | $6.39 |
| Resistance Level | $8.36 | $7.55 |
| Average True Range (ATR) | 0.36 | 0.56 |
| MACD | 0.01 | -0.19 |
| Stochastic Oscillator | 3.58 | 11.24 |
Price Performance
Historical ComparisonAbout PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.